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Renal tubulointerstitial injury from ureteral obstruction in the flow in the maturing kidney interferes with normal renal
neonatal rat is attenuated by IGF-1. growth and development [1]. This includes impairment
Background. The administration of insulin-like growth of nephrogenesis and delayed glomerular, tubular, andfactor-1 (IGF-1) has been shown to ameliorate the renal injury
interstitial maturation [2]. In addition, unilateral ureteralresulting from ischemic acute renal failure. As there are a
obstruction (UUO) in the developing rat induces a finelynumber of similarities between acute renal failure and obstruc-
tive nephropathy, we examined the effects of IGF-1 on the regulated enhanced growth of the intact opposite kidney,
renal cellular response to unilateral ureteral obstruction which is directly proportional to the duration of obstruc-
(UUO) in the neonatal rat.
tion [3]. The changes in renal growth induced by UUOMethods. Forty-five rats were subjected to UUO or sham
are associated with marked hemodynamic effects, includ-operation within the first 48 hours of life and received IGF-1
(2 mg/kg/day) or saline for the following three or seven days, ing vasoconstriction of the obstructed kidney and vasodi-
after which kidneys were removed for study by morphometry lation of the intact opposite kidney [4, 5]. This is medi-
and immunohistochemistry. To determine the effects of UUO
ated at least in part by activation of the renin-angiotensinon endogenous expression of IGF-1 and its receptor, six addi-
system [6]. The renal tubular consequences of UUOtional rats were subjected to UUO or sham operation, and
mRNA was measured by solution hybridization. in early development include a suppression of cellular
Results. There was no effect of seven days of UUO on the proliferation and marked activation of apoptosis [7].
renal expression of endogenous IGF-1 or its receptor. More- This is accompanied by suppression of renal epidermal
over, seven days of exogenous IGF-1 did not improve the
growth factor (EGF) expression and stimulation of trans-suppression of nephrogenesis, the delay in glomerular matura-
forming growth factor-b1 (TGF-b1) expression [1].tion, or the reduction in tubular proliferation induced by ipsilat-
eral UUO. However, in the obstructed kidney, IGF-1 reduced As a consequence of tubular injury, epithelial cells
tubular expression of vimentin, apoptosis, and tubular atrophy undergo phenotypic transformation and express vimen-
by 38 to 50% (P , 0.05). In addition, IGF-1 also decreased tin, an intermediate filament protein normally producedrenal interstitial collagen deposition in the obstructed kidney
only by mesenchymal cells, as well as clusterin, a glyco-by 44% (P , 0.05). Following three days of UUO, the adminis-
protein that is induced by tissues undergoing apoptosistration of IGF-1 also reduced tubular apoptosis (P , 0.05),
but did not alter tubular proliferation. [2]. There is progressive tubular atrophy and interstitial
Conclusions. IGF-1 has a profound salutary effect on the fibrosis [3]. The latter is associated with the expression
tubular and interstitial response to UUO in early development,
of a-smooth muscle actin by interstitial fibroblasts [1], awithout affecting glomerular injury or development. These re-
characteristic of myofibroblasts, which play a role in thesults suggest that IGF-1 may have therapeutic potential in the
management of congenital obstructive nephropathy. deposition of extracellular matrix and progressive inter-
stitial fibrosis [8].
There are a number of parallels between the renal
Obstructive nephropathy is a major cause of renal response to UUO and the renal response to ischemia.
failure in infants and children, as obstruction to urinary
In both, there is vasoconstriction, tubular obstruction
with dilation, and activation of apoptosis [9, 10]. There is
also suppression of renal EGF and activation of vimentinKey words: development, unilateral ureteral obstruction, insulin-like
growth factor-1, apoptosis, congenital obstructive nephropathy. and clusterin expression [11, 12]. Following relief of ob-
struction or following reperfusion after renal ischemia,
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tubular apoptosis. There remains, however, damage to To determine the effects of UUO on the relative abun-
dance of renal mRNA for IGF-1 and its receptor,the tubules and interstitium. This has prompted a search
for therapeutic approaches to speed and enhance recov- six additional rats were subjected to UUO or sham oper-
ation, as mentioned previously in this article, and kidneysery from ischemic acute renal failure.
Insulin-like growth factor-1 (IGF-1) is a peptide were harvested seven days later. Because infusion of
IGF-1 has been shown have no effect on renal IGF-1growth factor produced by the collecting duct of the
adult kidney [13, 14], and its receptors are present in or IGF-1 receptor mRNA [19], kidneys from rats receiv-
ing IGF-1 or saline were not studied.glomeruli and on the basolateral membrane of renal
proximal tubular cells [15]. In the developing rat kidney,
ImmunohistochemistryIGF-1 mRNA levels increase in linear fashion through-
out the first month of postnatal life [16], and in the Kidneys were fixed in 10% phosphate-buffered forma-
lin and were dehydrated, embedded in paraffin, and sec-developing rabbit, tubular IGF-1 receptor (IGF-1R)
mRNA increases during terminal maturation of the tu- tioned at 4 mm through a coronal plane at the point of
greatest distance between the upper and lower poles.bules [17]. Following ischemic injury, renal IGF-1 is sup-
pressed [18, 19]. The administration of exogenous IGF-1 Immunohistochemical localization was performed using
the avidin-biotin immunoperoxidase method (Vectastainaccelerates recovery from ischemic acute renal failure.
There is increased survival and glomerular filtration rate, ABC Kit; Vector Laboratories, Burlingame, CA, USA).
The primary antibodies used were monoclonal mousewith enhanced proliferation and reduced apoptosis of
tubular cells [18–21]. antirat proliferating cell nuclear antigen (PCNA) diluted
1:150 in phosphate-buffered saline (PBS; Vector Labora-After 10 days UUO in adult rats, renal immunoreac-
tive IGF-1 is reduced in the obstructed kidney and is tories), EGF diluted 1:200 (Biomedical Technologies,
Inc., Stoughton, MA, USA), monoclonal mouse antihu-increased in the opposite kidney [22]. The expression of
renal IGF-1 (or of its receptor) has not been reported man vimentin (1:650; Sigma Chemical Co., St. Louis,
MO, USA), monoclonal rabbit antirat clusterin (1:50;previously in the developing rat with UUO. Because
IGF-1 stimulates renal growth [15], we hypothesized that Upstate Biotechnology, Lake Placid, NY, USA), and
monoclonal anti–a-smooth muscle-specific actin (1:400;its expression is reduced in the neonatal kidney with
ipsilateral UUO. In view of the similarities between is- Sigma Chemical Co.). Apoptotic nuclei were labeled us-
ing the Tdt uridine-nick-end-label (TUNEL) techniquechemic renal injury and obstructive nephropathy, we also
hypothesized that IGF-1 would attenuate renal injury (Apoptag; Oncor, Gaithersburg, MD, USA) [23]. Sec-
tions were counterstained with Gill’s #2 hematoxylin orresulting from UUO. Experiments were therefore de-
signed to measure the renal cellular responses to exoge- methylene blue and were dehydrated and mounted for
examination by light microscopy. As a negative control,nous IGF-1 in neonatal rats with UUO.
the primary antiserum was replaced by nonimmune rab-
bit serum, and no staining occurred.
METHODS
Preparation of animals Morphometric analysis
Image analysis software (Mocha 1.2; Jandel Scientific,Experiments were performed using 45 Sprague-Daw-
ley rats subjected to complete left ureteral obstruction San Rafael, CA, USA) was used to examine kidneys by
light microscopy at 3400 magnification, with the ob-or sham operation within the first 48 hours of life, as
described previously [23]. Briefly, the ureter was ligated server blinded to the treatment group.
Number of glomeruli and glomerular maturation. Theunder general anesthesia (halothane and oxygen), after
which the pup was returned to its mother. Starting the number of glomeruli per section was determined as de-
scribed previously, using sections stained with periodicday following the operation, 24 pups were injected subcu-
taneously with recombinant IGF-1 (a gift of Genentech, acid-Schiff (PAS) [2, 25]. The maturation index of each
glomerulus per field was determined as described pre-Inc., South San Francisco, CA, USA) for three or seven
days at a daily dose of 2 mg/kg body wt. Twenty-one viously [26]. Glomeruli were scored as immature, inter-
mediate, or mature based on the number of capillaryrats were injected with saline vehicle to serve as controls.
The dose of IGF-1 was chosen on the basis of previous loops and the phenotype of podocytes [26].
Tubules and interstitium. Ten nonoverlapping fieldsstudies showing that doses of 0.4 to 1.5 mg/kg/day attenu-
ate renal ischemic injury [18, 20] and that the administra- were scanned, and for sections stained for PCNA, apo-
ptosis, or vimentin, the number of labeled tubular andtion of 3 mg/kg/day to young rats for 60 days did not
result in glomerular or tubulointerstitial lesions [24]. interstitial cells was counted in each field. For EGF, the
fraction of tubules in the field with positive immunostain-Rats were sacrificed three or eight days after operation,
and kidneys were removed, weighed, and processed for ing was compared with the total number of tubules per
field. For clusterin staining, the number of positive-stain-histologic study.
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ing tubules was counted for the entire section. For quan- the gels was performed using Kodak X-AR film (East-
man Kodak, Rochester, NY, USA) and two intensifyingtitation of tubular atrophy, sections were processed with
PAS, and atrophic tubules were identified in 50 fields screens at 2808C. The bands from the protected assay
were quantitated with a PhosphorImager apparatus us-by thickening of the basement membrane [3]. Interstitial
collagen was identified by blue color in sections stained ing ImageQuant software (Molecular Dynamics, Sun-
nyvale, CA, USA), as described previously [32].with Masson trichrome [3]. The distribution of interstitial
a-smooth muscle actin and collagen was determined by
Statistical analysissuperimposing the image of the field on a grid, and the
number of grid points overlapping interstitial a-smooth Data are presented as mean 6 SE. Comparisons be-
tween groups were made using two-way analysis of vari-muscle actin or collagen was counted for each of 15
fields. ance (with ureteral occlusion and IGF-1 treatment as
independent variables), followed by Student–Newman–
RNA analysis by solution hybridization/RNase Kuels multiple comparison test. Comparisons between
protection assay left and right kidneys were performed using the Student
t-test for paired data. Statistical significance was definedLevels of IGF-1 and IGF-1 receptor message in renal
tissue were determined by solution hybridization/RNase as P , 0.05.
protection assays using total kidney RNA. To isolate
RNA, kidney tissue was homogenized with a Polytron
RESULTS
(Brinkmann Instruments, Westbury, NY, USA), and
Characteristics of ratsRNA was extracted by the guanidinium-isothiocyanate/
cesium chloride technique [27]. The RNA was quanti- As shown in Tables 1 and 2, there was no effect of
UUO or of IGF-1 administration on body weight at thetated on the basis of its absorbence at 260 nm. The
quantitation and integrity of the RNA preparations were time of the study. Compared with sham-operated rats,
the kidney/body wt ratio was increased by seven daysconfirmed by computer-assisted video densitometry of
photographs taken with a video camera. The program (but not by 3 days) ipsilateral UUO, and there was no
additional effect of IGF-1. The relative number of glo-NIH Image (Dr. W. Rasband, NIH, Bethesda, MD,
USA) was used to analyze the digitized data of methyl- meruli and the glomerular maturation index were sig-
nificantly decreased by seven-days ipsilateral UUO,ene blue-stained 28S and 18S ribosomal RNA bands
after electrophoresis through 1.25% agarose-2.2 mol/L whereas the administration of IGF-1 had no additional
effect.formaldehyde gels of 5 mg aliquots of total RNA [28].
Antisense RNA probes. A 376 bp Sau3A-EcoRI
IGF-1 and IGF-1 receptor mRNAcDNA fragment of the rat IGF-1 subcloned in a pGEM-3
vector was linearized with HindIII, and an antisense As shown in Figure 1, there was no effect of UUO on
the expression of IGF-1 or its receptor in ipsilateral orRNA was transcribed using T7 polymerase. The use of
this probe in protection assays yields a 224-base major opposite kidneys of neonatal rats after seven days of
obstruction. Densitometric analysis did not reveal anyband and a much less abundant 386-base band [29]. A
265 bp EcoRI-RsaI cDNA fragment of the rat IGF-1 significant differences between groups.
receptor subcloned into the plasmid Vector pGEM-3
Renal tubular effects of IGF-1was linearized with EcoRI, and a 305-base antisense
RNA probe was transcribed using SP6RNA polymerase. As shown in Figures 2A and 3A, renal tubular cell
proliferation was decreased by 50% as a result of sevenThis probe produces a protected band of 265 bases when
hybridized with rat RNA [30]. days of UUO, but IGF-1 had no additional effect. In
contrast, as shown in Figure 4A, renal tubular cell prolif-Solution hybridization/RNase protection assays. Anti-
sense RNA probes were labeled with g[32P]-UTP using eration was not altered after three days of UUO. Renal
tubular expression of EGF was reduced by 20% as athe Riboprobe Gemini System (Promega, Madison, WI,
USA). Hybridizations were performed as previously de- consequence of seven days of UUO, an effect that was
not altered by IGF-1 administration (Figs. 2B and 3B).scribed [31]. Briefly, 15 mg aliquots of total RNA were
hybridized with a 200,000 dpm probe at 458C for 16 However, renal tubular apoptosis (which was markedly
stimulated by ipsilateral UUO) was reduced by 50% inhours. As an internal control for potential losses during
the processing of the samples, equal amounts (2000 dpm) rats receiving IGF-1 for either three or seven days (Figs.
2C, 3C, and 4C). Renal tubular expression of vimentin,of [32P]end-labeled AviII-digested pGEM-4Z DNA (1.7
kb in size) were added to each RNA sample before which is normally nearly absent, was also significantly
reduced in the seven-day obstructed kidney by the ad-ethanol precipitation. After RNase digestion, protected
probe bands were denatured and resolved on 8% ministration of IGF-1 (Figs. 2D and 3D).
Although expression of clusterin was markedly stimu-polyacrylamide-6 mol/L urea gels. Autoradiography of
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Table 1. Characteristics of rats following seven days of UUO or sham operation
UUO saline UUO IGF-1
Sham
Sham saline UUO Intact IGF-1 UUO Intact
Body weight g 18.861.3 17.861.1 18.461.0 17.061.1
Kidney/body weight ratio 0.6060.02 0.7660.10a 0.6460.04 0.5760.02 0.6760.03a 0.7060.02
Number of glomeruli per section 280610 12269a 26267 27569 13268a 25667
Glomerular maturation index 1.8060.03 1.3560.04a 1.7660.04 1.8060.03 1.4160.02a 1.8360.03
a P , 0.05 vs. Sham
Table 2. Characteristics of rats following three days of UUO or sham operation
UUO saline UUO IGF-1
Sham
Sham saline UUO Intact IGF-1 UUO Intact
Body weight g 12.060.2 12.560.3 13.060.5 12.760.5
Kidney/body weight ratio 0.5260.04 0.6560.04 0.5860.02 0.5460.01 0.5860.04 0.5760.02
Fig. 1. Solution hybridization/RNase protec-
tion assay of kidney insulin-like growth fac-
tor-1 (IGF-1) and IGF-1 receptor mRNA
levels in neonatal rats. Fifteen microgram ali-
quots of kidney total RNA were used. The
protected bands are shown, together with the
size marker. Sham, lanes 1–3; intact kidney,
lanes 4–6; UUO kidney, lanes 7–9.
lated by seven days of ipsilateral UUO, the administra- DISCUSSION
tion of IGF-1 did not modulate this action (Figs. 2E The results of the mRNA analysis reveal that there
and 3E). The density of atrophic tubules, however, was were no detectable changes induced by UUO on the
reduced by 38% in the obstructed kidney of rats receiv- expression of IGF-1 or its receptor in the neonatal kid-
ing IGF-1 for seven days (Figs. 2F and 3F). ney. In their study of the adult kidney following UUO,
Marshall et al reported a decrease in immunoreactive
Renal interstitial effects of IGF-1 IGF-1 (factored for kidney weight) in the obstructed
kidney [22]. However, the absolute renal IGF-1 contentAs shown in Figure 3 G and H, seven days of UUO
does not decrease more than approximately 20% in theinduced a significant increase in interstitial cell prolifera-
first 10 days after ipsilateral UUO, suggesting that edemation and apoptosis, but there was no additional effect of
and interstitial infiltrate may account for dilution of theIGF-1. As shown in Figures 4B, three days of UUO also
peptide in the obstructed kidney [22]. Nevertheless, renal
induced an increase in interstitial cell proliferation, and
IGF-1 concentration is increased in the contralateral kid-
IGF-1 did not significantly modulate this increase. As ney one day following UUO and remains elevated for
shown in Figure 4D, three days of UUO did not affect at least 10 days [22]. Immunoreactive IGF-1 is also in-
interstitial cell apoptosis, and there was no additional creased in the remaining kidney five days after unilateral
effect of IGF-1. The expression of a-smooth muscle actin nephrectomy in the adult rat, but levels return to normal
was also significantly greater in seven-day obstructed by 30 days [33]. Renal IGF-1 mRNA levels are increased
compared with sham-operated and intact kidneys, with fourfold 24 and 48 hours after unilateral nephrectomy
no modulation by the administration of IGF-1 (Figs. in the weanling rat, but there is no early response in the
2G and 3I). In contrast, the distribution of interstitial adult [34]. Thus, IGF-1 may play a role in the compensa-
collagen in the seven-day obstructed kidney was reduced tory growth of a kidney, but the response could depend
on the timing of loss of functioning renal mass, as well44% as a result of IGF-1 administration (Figs. 2H and 3J).
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Fig. 2. Representative photomicrographs of kidneys following seven days of ipsilateral unilateral ureteral obstruction (UUO) from neonatal rats
showing immunohistochemical results. For each pair of figures, kidney from a vehicle-treated rat is on the left, and IGF-1–treated rat is on the
right. (A) Proliferating cells identified by positive nuclear staining for proliferating cell nuclear antigen (PCNA). These are dark-staining nuclei.
(B) Immunolocalization (brown staining) of epidermal growth factor in dilated tubules (*). (C) Apoptotic cells are identified by the TUNEL
technique, which stains fragmented nuclear DNA. Arrowheads indicate typical “apoptotic bodies”: brown-staining nuclear fragments with vacuoles.
(D) Immunolocalization of vimentin, an intermediate filament protein normally produced by mesenchymal (but not epithelial) cells. Arrowheads
indicate vimentin-positive dilated tubules, whereas the asterisks indicate blood vessels with vimentin-positive smooth muscle cells. (E) Immunolocali-
zation of clusterin, a glycoprotein produced in response to renal injury. The apical pole of epithelial cells in dilated tubules contains clusterin (*).
(F ) Atrophic tubule (*) identified by thickened tubular basement membrane, stained by PAS. (G) Immunolocalization of a-smooth muscle actin
(brown stain) in the interstitial space of hydronephrotic kidney. (H ) Localization of collagen (blue stain) in expanded interstitial space of
hydronephrotic kidney stained with Masson-trichrome.
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Fig. 3. Summary of morphometric and im-
munohistochemical examination of tubules
and interstitium following seven days of uni-
lateral ureteral obstruction (UUO) or sham
operation. (A) Number of proliferating tubu-
lar cells/field determined by PCNA immuno-
staining. (B) Fraction of tubules/section with
epidermal growth factor (EGF)-positive im-
munostaining. (C) The number of apoptotic
tubular cells/field determined by TUNEL
technique. (D) The number of vimentin-posi-
tive tubular cells/field. (E) The number of tu-
bules/section with clusterin-positive immuno-
staining. (F ) The number of atrophic tubules/
section. (G) The number of proliferating inter-
stitial cells/field. (H ) The number of apoptotic
interstitial cells/field. (I ) The relative area of
interstitial a-smooth muscle actin distribution.
(J ) The relative area of interstitial collagen
distribution. The results are mean 6 SE. Sym-
bols are ( ) kidneys of sham-operated rats;
(j) kidneys with ipsilateral UUO; ( ) intact
opposite kidneys. For each variable, UUO
kidney was different from sham and intact
opposite kidneys (P , 0.05); *P , 0.05 vs.
saline-treated group.
as on the maturation of the kidney. This study suggests dance of IGF-1 receptor, an effect that is not altered by
the administration of exogenous IGF-1 [35].that neither the impaired growth of the obstructed kid-
ney nor the accelerated growth of the opposite kidney Administration of IGF-1 did not accelerate somatic
growth of sham-operated or UUO rats in this study. Thiscan be related to altered regulation of mRNA for IGF-1
or its receptor seven days after UUO in the neonate. In contrasts with the findings in female adult rats, in which
body weight increased after seven days of administrationcontrast, ischemic acute renal failure reduces the abun-
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Fig. 4. Summary of tubular and interstitial
cellular proliferation and apoptosis following
three days of unilateral ureteral obstruction
(UUO) or sham operation. (A) Number of
proliferating tubular cells/field determined by
PCNA immunostaining. (B) Number of prolif-
erating interstitial cells/field. (C) Number of
apoptotic tubular cells/field determined by
TUNEL technique. (D) Number of apoptotic
interstitial cells/field. The results are mean 6
SE. Symbols are ( ) kidneys of sham-oper-
ated rats; (j) kidneys with ipsilateral UUO;
( ) intact opposite kidneys. For each vari-
able, UUO kidney was different from sham
and intact opposite kidneys (P , 0.05); *P ,
0.05 vs. saline-treated group.
of IGF-1 at 2 mg/kg/day [24]. However, exogenous IGF-1 In contrast to its lack of effect on tubular cell prolifera-
tion, IGF-1 significantly reduced tubular cell expressionenhances EGF receptor activation in a model of post-
ischemic acute renal failure [36], and we and others have of vimentin, which is associated with phenotypic trans-
formation of cells [2]. A change in cell shape and lossdemonstrated that exogenous EGF reduces growth of
newborn rats [37, 38]. It is likely that unique characteris- of polarity consequent to acquisition of mesenchymal
characteristics are likely to contribute to susceptibilitytics of the neonatal animal account for the lack of in-
creased somatic growth following exogenous IGF-1. to apoptosis through anoikis (“homelessness” due to loss
of cell–cell and cell–matrix contact) [42]. As shown inAlthough shown to be a renal mitogen [24], the admin-
istration of exogenous IGF-1 did not alter renal mass, the present study, tubular apoptosis in the obstructed
kidney was reduced by 50% as a result of either threeglomerular number, glomerular maturation, or tubular
cell proliferation in the normal or obstructed neonatal or seven days of IGF-1 treatment. Anoxic injury to proxi-
mal tubular cells in culture also leads to cell detachment,rat kidney. This is in contrast to the effect of exogenous
EGF, which accelerates glomerular maturation and tu- which can be abrogated by incubation with IGF-1 [21].
IGF-1 has also been found to inhibit apoptosis by attenu-bular cell proliferation in the obstructed kidney [39].
Although there was no effect of exogenous IGF-1 on ating Bax induction, increasing bcl-xL expression, reduc-
ing caspase 3 activation, and other pathways [43–45].tubular expression of EGF, IGF-1 may enhance EGF
receptor activation by increasing expression of this re- The dissociation of apoptosis from tubular clusterin
expression in this study supports the hypothesis that thisceptor [36]. This may allow endogenous EGF to contrib-
ute to the salutary effect [23]. Conversely, IGF-1 expres- glycoprotein modulates, but does not mediate, apoptosis
[7]. However, the close correlation of tubular atrophysion in collecting ducts is stimulated by EGF [40]. In the
present study, the lack of effect of exogenous IGF-1 on with apoptosis in this study is consistent with the hypoth-
esis that apoptosis contributes to tubular atrophy [46].renal cellular proliferation presumably relates to unique
characteristics of the neonatal kidney, as treatment of A similar relationship was demonstrated in neonatal rats
with UUO receiving exogenous EGF [2].mature rats with 4 mg/kg/day increased tubular cell pro-
liferation of intact kidneys [24]. Although we found no Although three-day UUO increased interstitial cell
proliferation, the administration of IGF-1 did not affecteffect of IGF-1 on renal cellular proliferation after either
three or seven days of administration in the neonate, it cellular proliferation or apoptosis in the renal intersti-
tium after either three or seven days of ipsilateral UUO.is possible that a higher dose or more prolonged adminis-
tration of IGF-1 would stimulate proliferation. The mode Moreover, IGF-1 did not affect the expression of
a-smooth muscle actin by interstitial fibroblasts. Theof administration of the growth factor may also play a
role, as intraparenchymal but not intra-arterial infusion phenotypic transformation of interstitial fibroblasts to
myofibroblasts occurs in the mature kidney followingof IGF-1 was shown to stimulate renal cellular prolifera-
tion [41]. UUO [47], and myofibroblasts have increased fibrogenic
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